维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Ritgen M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	High efficacy but considerable toxicity of campath - 1H consolidation therapy in CLL patients responding to fludarabine - results of a randomized phase Ⅲ trial显示文摘	Ritgen M Jaeger G	2003	Proc Am Soc Clin Oncol2003，22，：	1
	2	Allogeneic stem cell transplan-tation provides durable disease control in poor-risk chronic lymphocyticleukemia : long-term clinical and MRD results of the German CLLStudy Group CLI3X trial显示文摘	Dreger P Dohner H Ritgen M	2010	Blood2010，116，14：	1
	3	Significance of minimal residual disease in lymphoid malignancies 显示文摘	Bruggemann M Pott C Ritgen M	2004	Acta Haematol2004，112，12：	1
	4	Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation 显示文摘	Bottcher S Ritgen M Pott C	2004	Leukemia2004，18，10：	1
	5	Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia:long-term clinical and MRD results of the German CLL Study Group CLL3Xtrial显示文摘	DREGER P DOHNER H RITGEN M	2010	Blood2010，116，：	1
	6	Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia:a multivariate analysis from the randomized GCLLSG CLL8trial显示文摘	BTTCHER S RITGEN M FISCHER K	2012	J Clin Oncol2012，30，：	1
	7	Graft-versusleukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR 显示文摘	Ritgen M Stilgenbauer S von-Neuhoff N	2004	Blood2004，104，8：	1
	8	Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lympho- cytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial 显示文摘	Bottcher S Ritgen M Fischer K	2012	J Clin Oncol2012，30，9：	1
	9	Consolidation with alemtuzumab in patients with chroniclymphocytic leukemia(CLL)in first remission-experience on safety a)nd efficacy within a randomized multicenter phase III trial of the German CLL Study Group(GCLLSG)显示文摘	WENDTN C M RITGEN M SCHWEIGHOFER C D	2004	Leukemia2004，18，6：	1
	10	Unmutated immunoglobulin variable heavy-chain gene Status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia显示文摘	Ritgen M Lange A Stilgenbauer S	2003	Blood2003，101，5：	1
	11	Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab 显示文摘	Fink AM Bottcher S Ritgen M	2013	Leukemia2013，27，9：	1
	12	International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia显示文摘	Rawstron AC Villamor N Ritgen M		0，，05：	1
	13	Minimal Re-sidual Disease Quantification Is an Independent Predic-tor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia:A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial显示文摘	Bottcher S Ritgen M Fischer K		0，，09：	1
	14	Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GGLLSG CLL8 trial显示文摘	Biittcher S Ritgen M Fischer K	2012	J Clin On- col2012，30，9：	1
	15	Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophos- phamide and rituximab显示文摘	Fink AM Botteher S Ritgen M	2013	Leukemia2013，27，9：	1
	16	MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR显示文摘	Pott C Brüggemann M Ritgen M	2013	Methods Mol Biol2013，971，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费